Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 84.47
-0.73 (-0.86%)
Jun 15, 2026, 3:49 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 828.82 million as of June 16, 2026. Its market cap has increased by 124.12% in one year.
Market Cap
828.82M
Enterprise Value
519.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
84.47
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 828.82M, an increase of 1,453.99%. That is a compound annual growth rate of 66.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 828.82M | -3.62% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 552.01M |
| Satellos Bioscience | 167.07M |
| Helix BioPharma | 120.68M |
| Telescope Innovations | 68.68M |
| Sharp Therapeutics | 63.16M |
| ME Therapeutics Holdings | 59.80M |
| Sernova Biotherapeutics | 54.67M |
| NurExone Biologic | 47.86M |